CADL · Forms 3, 4, 5
Insider trades at Candel Therapeutics, Inc.
2 insiders sold $3.2M of Candel Therapeutics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Candel Therapeutics, Inc. (CADL) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nicoletta Loggia | Director | Options or other derivatives | Form 4 | ||||
| Joseph C Papa | Director | Options or other derivatives | Form 4 | ||||
| Paul B Manning | Director | Options or other derivatives | Form 4 | ||||
| Paul Peter Tak | Chief Executive Officer | Sell | 59,379 | $10.46 | $621K | Form 4 | |
| Paul Peter Tak | Chief Executive Officer | Option exercise | 125,000 | $1.55 | $194K | Form 4 | |
| Paul Peter Tak | Chief Executive Officer | Sell | 220,866 | $11.50 | $2.5M | Form 4 | |
| Martine Zimmermann | Director | Options or other derivatives | Form 4 | ||||
| Martine Zimmermann | Director | Became an insider (Form 3) | Form 3 | ||||
| Seshu Tyagarajan | Chief Technology Officer | Sell | 7,000 | $12.00 | $84K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.